Govender, L., Mikulic, J., Wyss, J., Gaide, O., Thome, M., & Golshayan, D. (2020). Therapeutic Potential of Targeting Malt1-Dependent TCR Downstream Signaling to Promote the Survival of MHC-Mismatched Allografts. Front Immunol.
Dyfyniad Arddull ChicagoGovender, Lerisa, Josip Mikulic, Jean-Christophe Wyss, Olivier Gaide, Margot Thome, and Dela Golshayan. "Therapeutic Potential of Targeting Malt1-Dependent TCR Downstream Signaling to Promote the Survival of MHC-Mismatched Allografts." Front Immunol 2020.
Dyfyniad MLAGovender, Lerisa, et al. "Therapeutic Potential of Targeting Malt1-Dependent TCR Downstream Signaling to Promote the Survival of MHC-Mismatched Allografts." Front Immunol 2020.
Rhybudd: Mae'n bosib nad yw'r dyfyniadau hyn bob amser yn 100% cywir.